YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report)’s share price was up 5.1% during trading on Tuesday. The stock traded as high as $39.63 and last traded at $38.83. Approximately 250,718 shares were traded during mid-day trading, an increase of 5% from the average session volume of 239,079 shares. The stock had previously closed at $36.93.
YieldMax MRNA Option Income Strategy ETF Price Performance
The business has a 50 day moving average price of $25.23 and a two-hundred day moving average price of $20.35.
YieldMax MRNA Option Income Strategy ETF Company Profile
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
Featured Stories
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
